38.98 USD
▲+0.53+11.44%
盘后 34.98 0.00%
2026-08-03
市值
$1.76B
市盈率
—
EPS
-0.81
股息率
—
52 周区间
10.62 – 38.04
成交量
398.82K
Beta
—
目标价
45.00
52W 低 10.6252W 高 38.04
价格走势
公司简介
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM f...